J&J sees potential for 14 new multibillion-dollar drugs by 2025
(Reuters) – Johnson & Johnson expects to file for approval of 14 new drugs by 2025, and has projected average
Read more(Reuters) – Johnson & Johnson expects to file for approval of 14 new drugs by 2025, and has projected average
Read moreBritish drug major AstraZeneca (AZN.L,AZN) announced Thursday that new analyses of two AZD7442 COVID-19 Phase III trials in high-risk populations
Read moreEuropean stocks are expected to open around the flatline on Thursday amid market concerns around the region's inflation outlook. The
Read moreAlthough futures were fairly positive, markets opened on a negative note, despite strong earnings reports from Home Depot, Target and
Read moreHDFC was the top loser in the Sensex pack, shedding over 1%, followed by Dr Reddy’s, Reliance Industries, Axis Bank,
Read moreLONDON (Reuters) – British electric truck startup Tevva said on Tuesday it had raised $57 million in its latest funding
Read moreWASHINGTON (Reuters) -Flanked by black-clad bodyguards and making ominous comments about President Joe Biden, former President Donald Trump’s longtime adviser
Read moreU.S. stock futures rose Monday, with the Dow indicated to open more than 100 points higher. Wall Street ended on
Read moreHong Kong (CNN Business)The Beijing Stock Exchange, President Xi Jinping’s new financial baby, is finally here. The bourse was first
Read more